Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 6/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | PPARG | P37231 | 5/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | FABP1 | P07148 | 1/20 | 0.42 |
| ▸ | EDNRB | P24530 | 3/20 | 0.41 |
| ▸ | EDNRA | P25101 | 3/20 | 0.41 |
| ▸ | PTGES | O14684 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6092494 | 0.90 | SERPINE1 (0.47) | SERPINE1FAAHPPARGMAPK8PPARA | |
| SCHEMBL6091399 | 0.89 | SERPINE1 (0.46) | SERPINE1FAAHPPARGPPARAFABP1 | |
| SCHEMBL2810203 | 0.82 | SERPINE1 (0.62) | SERPINE1PPARGEDNRBEDNRA | |
| SCHEMBL2807015 | 0.82 | SERPINE1 (0.62) | SERPINE1PPARGEDNRBEDNRAPTGES | |
| SCHEMBL2808240 | 0.82 | SERPINE1 (0.57) | SERPINE1PPARGEDNRBEDNRA | |
| SCHEMBL6090004 | 0.81 | CCR8 (0.43) | SERPINE1FAAHPPARGPPARAFABP1 | |
| SCHEMBL5751151 | 0.80 | FAAH (0.39) | SERPINE1FAAHPPARGMAPK8PPARA | |
| SCHEMBL2810671 | 0.80 | SERPINE1 (0.59) | SERPINE1PPARGEDNRBEDNRA | |
| SCHEMBL2810724 | 0.79 | SERPINE1 (0.64) | SERPINE1PPARGMAPK8EDNRBEDNRA | |
| SCHEMBL5737954 | 0.77 | SERPINE1 (0.53) | SERPINE1PPARGMAPK8PPARAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160879-A1 | Indoles useful in the treatment of inflammation | BIOLIPOX AB (SE) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160879-A1 | Indoles useful in the treatment of inflammation | IDO1, PTGS1, IDO2 | SERPINE1 508/4885FAAH 435/4885PPARG 481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.